ammad ahmad farooqi
Institute of Biomedical and Genetic Engineering (IBGE)
Islamabad, Pakistan
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Editors
Review Editors
alexandra r fernandes
Faculty of Sciences and Technology, New University of Lisbon
Caparica, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
gino b ferraro
Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
andy finch
Centre for Tumor Biology, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
paul b fisher
Virginia Commonwealth University
Richmond, United States
Review Editor
Cancer Molecular Targets and Therapeutics
marco folini
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
olivia l francis-boyle
Loma Linda University
Loma Linda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
marina santiago franco
University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Review Editor
Cancer Molecular Targets and Therapeutics
sabrina fritah
Luxembourg Institute of Health
Luxembourg, Luxembourg
Review Editor
Cancer Molecular Targets and Therapeutics
aliesha gonzalez-arenas
Institute of Biomedical Research, National Autonomous University of Mexico
Mexico City, Mexico
Review Editor
Cancer Molecular Targets and Therapeutics
paolo armando gagliardi
Department of Oncology, School of Medicine, University of Turin
Torino, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
andrzej gamian
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
paolo gandellini
University of Milan
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
sara gandolfi
CRCI2NA INSERM U1307
Nantes, France
Review Editor
Cancer Molecular Targets and Therapeutics
prakash gangadaran
Kyungpook National University
Daegu, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
yuen gao
Michigan State University
East Lansing, United States
Review Editor
Cancer Molecular Targets and Therapeutics